SPA
CNMD icon

Sherbrooke Park Advisers’s CONMED CNMD Stock Holding History

Sherbrooke Park Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,477
Closed -$211K – 267
2025
Q3 		$211K Buy
+4,477
New +$232K 0.1% 370
2024
Q3 		– Sell
-5,069
Closed -$351K – 959
2024
Q2 		$351K Sell
5,069
-1,573
-24% -$115K 0.06% 560
2024
Q1 		$532K Buy
+6,642
New +$592K 0.1% 336

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Sherbrooke Park Advisers's CNMD Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of CONMED (CNMD) in Q4 2025, closing a stake of 4,477 shares — an estimated $211K sold.

Sherbrooke Park Advisers first reported a position in CNMD in Q1 2024 and held it in 3 quarters. The position peaked at $532K in Q1 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 4,477 CONMED shares in Q4 2025, an estimated $211K.
  • Sherbrooke Park Advisers first reported a position in CONMED in Q1 2024 and held it in 3 quarters.
  • Sherbrooke Park Advisers's CONMED position peaked at $532K in Q1 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.